{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T15:25:30Z","timestamp":1773933930884,"version":"3.50.1"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001332","name":"Council for Scientific and Industrial Research, South Africa","doi-asserted-by":"publisher","award":["202511008623"],"award-info":[{"award-number":["202511008623"]}],"id":[{"id":"10.13039\/501100001332","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["HEK293-ACE2\/TMPRSS2"],"award-info":[{"award-number":["HEK293-ACE2\/TMPRSS2"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["HEK293-ACE2"],"award-info":[{"award-number":["HEK293-ACE2"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["IPA\/2020\/00016 8"],"award-info":[{"award-number":["IPA\/2020\/00016 8"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001412","name":"Council of Scientific &amp; Industrial Research","doi-asserted-by":"publisher","award":["MLP2037"],"award-info":[{"award-number":["MLP2037"]}],"id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001412","name":"Council of Scientific &amp; Industrial Research","doi-asserted-by":"publisher","award":["HCP-41"],"award-info":[{"award-number":["HCP-41"]}],"id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012339","name":"CSIR \u2013 Indian Institute of Chemical Biology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ejmech.2025.118462","type":"journal-article","created":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T07:42:22Z","timestamp":1765870942000},"page":"118462","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Targeted screening and rational optimization of bazedoxifene analogs as pan-variant SARS-CoV-2 entry inhibitors with improved pharmacokinetics"],"prefix":"10.1016","volume":"304","author":[{"given":"Binita","family":"Patra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nirmal","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akshay","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sahil","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renuga","family":"Devi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biswajit","family":"Kundu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nanda Kumar","family":"Raja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Israful","family":"Hoque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soupayan","family":"Pal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anindita","family":"Dey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jafar","family":"Sarif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nittu","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nandha","family":"Kumaar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravneet","family":"Singh Chawla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uddipta Ghosh","family":"Dastidar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alna Kuriyickal","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanagasabai","family":"Balamurugan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bokara Kiran","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajesh P.","family":"Ringe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dipyaman","family":"Ganguly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krishan Gopal","family":"Thakur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7831-1795","authenticated-orcid":false,"given":"Arindam","family":"Talukdar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.118462_bib1","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/s41579-021-00573-0","article-title":"SARS-CoV-2 variants, spike mutations and immune escape","volume":"19","author":"Harvey","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ejmech.2025.118462_bib2","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41586-021-04385-3","article-title":"Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies","volume":"602","author":"Cao","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2025.118462_bib3","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1056\/NEJMc2106083","article-title":"BNT162b2-Elicited neutralization against new SARS-CoV-2 spike variants","volume":"385","author":"Yang","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2025.118462_bib4","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2022.2057161","article-title":"Research progress on vaccine efficacy against SARS-CoV-2 variants of concern","volume":"18","author":"Bian","year":"2022","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.ejmech.2025.118462_bib5","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s12916-022-02397-y","article-title":"Effectiveness of COVID-19 vaccines against SARS-CoV-2 variants of concern: a systematic review and meta-analysis","volume":"20","author":"Zeng","year":"2022","journal-title":"BMC Med."},{"key":"10.1016\/j.ejmech.2025.118462_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114367","article-title":"Paxlovid (Nirmatrelvir\/Ritonavir): a new approach to Covid-19 therapy?","volume":"162","author":"Hashemian","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2025.118462_bib7","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1126\/science.abl4784","article-title":"An oral SARS-CoV-2 mpro inhibitor clinical candidate for the treatment of COVID-19","volume":"374","author":"Owen","year":"2021","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.ejmech.2025.118462_bib8","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1124\/dmd.121.000801","article-title":"Disposition of Nirmatrelvir, an orally bioavailable inhibitor of SARS-CoV-2 3C-Like protease, across animals and humans","volume":"50","author":"Eng","year":"2022","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejmech.2025.118462_bib9","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1056\/NEJMoa2204919","article-title":"Nirmatrelvir use and severe Covid-19 outcomes during the Omicron surge","volume":"387","author":"Ronen","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2025.118462_bib10","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/s41422-022-00618-w","article-title":"SARS-CoV-2 Omicron variant is highly sensitive to Molnupiravir, Nirmatrelvir, and the combination","volume":"32","author":"Li","year":"2022","journal-title":"Cell Res."},{"key":"10.1016\/j.ejmech.2025.118462_bib11","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1001\/jama.2023.16666","article-title":"Outpatient treatment for COVID-19","volume":"330","author":"Raglow","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.ejmech.2025.118462_bib12","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/s41573-023-00672-y","article-title":"Therapeutic strategies for COVID-19: progress and lessons learned","volume":"22","author":"Li","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2025.118462_bib13","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/s41573-023-00692-8","article-title":"Accelerating antiviral drug discovery: lessons from COVID-19","volume":"22","author":"von Delft","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2025.118462_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/molecules29235564","article-title":"Navigating the COVID-19 therapeutic landscape: unveiling novel perspectives on FDA-Approved medications, vaccination targets, and emerging novel strategies","author":"Barghash","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.118462_bib15","doi-asserted-by":"crossref","first-page":"9371","DOI":"10.1021\/acs.jmedchem.4c03093","article-title":"Strategic design and optimization of Umifenovir analogues: balancing antiviral efficacy and HERG toxicity against SARS-CoV-2","volume":"68","author":"Hoque","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118462_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010828","article-title":"An ACE2-dependent Sarbecovirus in Russian bats is resistant to SARS-CoV-2 vaccines","volume":"18","author":"Seifert","year":"2022","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ejmech.2025.118462_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114296","article-title":"Repurposing existing drugs for the treatment of COVID-19\/SARS-CoV-2 infection: a review describing drug mechanisms of action","volume":"183","author":"Yousefi","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118462_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.685308","article-title":"A repurposed drug screen identifies compounds that inhibit the binding of the COVID-19 spike protein to ACE2","volume":"12","author":"Tsegay","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118462_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115292","article-title":"Potential RNA-Dependent RNA polymerase (RdRp) inhibitors as prospective drug candidates for SARS-CoV-2","volume":"252","author":"Bekheit","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118462_bib20","doi-asserted-by":"crossref","first-page":"12500","DOI":"10.1021\/acs.jmedchem.2c01005","article-title":"Targeting SARS-CoV-2 main protease for treatment of COVID-19: covalent inhibitors structure\u2013activity relationship insights and evolution perspectives","volume":"65","author":"La Monica","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118462_bib21","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1021\/acsinfecdis.1c00070","article-title":"Small-molecule inhibitors of the coronavirus spike: ACE2 protein\u2013protein interaction as blockers of viral attachment and entry for SARS-CoV-2","volume":"7","author":"Bojadzic","year":"2021","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ejmech.2025.118462_bib22","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.3390\/jcm9041131","article-title":"Pharmacological therapeutics targeting RNA-dependent RNA polymerase, proteinase and spike protein: from mechanistic studies to clinical trials for COVID-19","volume":"9","author":"Huang","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ejmech.2025.118462_bib23","doi-asserted-by":"crossref","first-page":"712","DOI":"10.3390\/v16050712","article-title":"Research progress on spike-dependent SARS-CoV-2 fusion inhibitors and small molecules targeting the S2 subunit of spike","volume":"16","author":"Freidel","year":"2024","journal-title":"Viruses"},{"key":"10.1016\/j.ejmech.2025.118462_bib24","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1185\/03007991003795873","article-title":"Efficacy and safety of bazedoxifene, a novel selective estrogen receptor modulator for the prevention and treatment of postmenopausal osteoporosis","volume":"26","author":"Palacios","year":"2010","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.ejmech.2025.118462_bib25","first-page":"299","article-title":"Update on bazedoxifene: a novel selective estrogen receptor modulator","volume":"2","author":"Biskobing","year":"2007","journal-title":"Clin. Interv. Aging"},{"key":"10.1016\/j.ejmech.2025.118462_bib26","doi-asserted-by":"crossref","first-page":"4809","DOI":"10.1002\/jmv.27951","article-title":"Antiviral efficacy of selective estrogen receptor modulators against SARS-CoV-2 infection in vitro and in vivo reveals bazedoxifene acetate as an entry inhibitor","volume":"94","author":"Gen","year":"2022","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.ejmech.2025.118462_bib27","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/s41423-020-0374-2","article-title":"Fusion mechanism of 2019-NCoV and fusion inhibitors targeting HR1 domain in spike protein","volume":"17","author":"Xia","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.ejmech.2025.118462_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104792","article-title":"Coronavirus membrane fusion mechanism offers a potential target for antiviral development","volume":"178","author":"Tang","year":"2020","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2025.118462_bib29","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM structure of the 2019-NCoV spike in the prefusion conformation","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2025.118462_bib30","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein","volume":"181","author":"Walls","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2025.118462_bib31","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/s41401-020-0485-4","article-title":"Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19","volume":"41","author":"Huang","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejmech.2025.118462_bib32","doi-asserted-by":"crossref","first-page":"6150","DOI":"10.1128\/JVI.03372-12","article-title":"TMPRSS2 activates the human coronavirus 229E for cathepsin-independent host cell entry and is expressed in viral target cells in the respiratory epithelium","volume":"87","author":"Stephanie","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.ejmech.2025.118462_bib33","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2025.118462_bib34","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/infdis\/jiab010","article-title":"Nature and dimensions of systemic hyperinflammation and its attenuation by convalescent plasma in severe COVID-19","volume":"224","author":"Bandopadhyay","year":"2021","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ejmech.2025.118462_bib35","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/s41587-020-0631-z","article-title":"A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2\u2013spike protein\u2013protein interaction","volume":"38","author":"Tan","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ejmech.2025.118462_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.jviromet.2021.114297","article-title":"Two novel SARS-CoV-2 surrogate virus neutralization assays are suitable for assessing successful immunization with MRNA-1273","volume":"299","author":"Kr\u00fcttgen","year":"2022","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.ejmech.2025.118462_bib37","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1038\/s41598-022-07597-3","article-title":"Evaluation of a commercial ELISA as alternative to plaque reduction neutralization test to detect neutralizing antibodies against SARS-CoV-2","volume":"12","author":"Hofmann","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2025.118462_bib38","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/msb.2011.75","article-title":"Fast, scalable generation of high\u2010quality protein multiple sequence alignments using clustal omega","volume":"7","author":"Sievers","year":"2011","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.ejmech.2025.118462_bib39","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.devcel.2022.03.019","article-title":"Mitochondrial dynamics regulate genome stability via control of caspase-dependent DNA damage","volume":"57","author":"Cao","year":"2022","journal-title":"Dev. Cell"},{"key":"10.1016\/j.ejmech.2025.118462_bib40","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/s41586-022-04464-z","article-title":"ACE2 binding is an ancestral and evolvable trait of sarbecoviruses","volume":"603","author":"Starr","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2025.118462_bib41","doi-asserted-by":"crossref","first-page":"W296","DOI":"10.1093\/nar\/gky427","article-title":"SWISS-MODEL: homology modelling of protein structures and complexes","volume":"46","author":"Waterhouse","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2025.118462_bib42","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","article-title":"Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor","volume":"581","author":"Lan","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2025.118462_bib43","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ejmech.2025.118462_bib44","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1002\/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B","article-title":"Automated docking using a lamarckian genetic algorithm and an empirical binding free energy function","volume":"19","author":"Morris","year":"1998","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ejmech.2025.118462_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27134026","article-title":"Integration of ligand-based and structure-based methods for the design of small-molecule TLR7 antagonists","volume":"27","author":"Pal","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.118462_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112978","article-title":"Synthesis and characterization of new potent TLR7 antagonists based on analysis of the binding mode using biomolecular simulations","volume":"210","author":"Pal","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118462_bib47","doi-asserted-by":"crossref","first-page":"4776","DOI":"10.1021\/acs.jmedchem.0c00011","article-title":"A chemical switch for transforming a purine agonist for toll-like receptor 7 to a clinically relevant antagonist","volume":"63","author":"Mukherjee","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118462_bib48","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers","volume":"1\u20132","author":"Abraham","year":"2015","journal-title":"SoftwareX"},{"key":"10.1016\/j.ejmech.2025.118462_bib49","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.csbj.2019.02.006","article-title":"Ligand-based pharmacophore modeling, virtual screening and molecular docking studies for discovery of potential topoisomerase I inhibitors","volume":"17","author":"Pal","year":"2019","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.ejmech.2025.118462_bib50","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1002\/prot.22711","article-title":"Improved side-chain torsion potentials for the amber Ff99SB protein force field","volume":"78","author":"Lindorff-Larsen","year":"2010","journal-title":"Proteins"},{"key":"10.1016\/j.ejmech.2025.118462_bib51","doi-asserted-by":"crossref","DOI":"10.1093\/bioinformatics\/btad350","article-title":"The ACPYPE web server for small-molecule MD topology generation","volume":"39","author":"Kagami","year":"2023","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ejmech.2025.118462_bib52","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1063\/1.445869","article-title":"Comparison of simple potential functions for simulating liquid water","volume":"79","author":"Jorgensen","year":"1983","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.ejmech.2025.118462_bib53","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","article-title":"The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities","volume":"10","author":"Genheden","year":"2015","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.ejmech.2025.118462_bib54","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","article-title":"VMD: visual molecular dynamics","volume":"14","author":"Humphrey","year":"1996","journal-title":"J. Mol. Graph."},{"key":"10.1016\/j.ejmech.2025.118462_bib55","series-title":"Bazedoxifene, In: StatPearls","author":"Raina","year":"2025"},{"key":"10.1016\/j.ejmech.2025.118462_bib56","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1124\/dmd.108.023861","article-title":"Metabolic disposition of [14C]Bazedoxifene in healthy postmenopausal women","volume":"37","author":"Chandrasekaran","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejmech.2025.118462_bib57","doi-asserted-by":"crossref","first-page":"111607","DOI":"10.1021\/acs.jmedchem.2c00386","article-title":"Development, optimization, and in vivo validation of new imidazopyridine chemotypes as dual TLR7\/TLR9 antagonists through activity-directed sequential incorporation of relevant structural subunits","volume":"65","author":"Das","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118462_bib58","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.1039\/D5MD00252D","article-title":"Rational design and discovery of potent PROTAC degraders of ASK1: a targeted therapy in MASH","volume":"16","author":"Sarkar","year":"2025","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118462_bib59","doi-asserted-by":"crossref","first-page":"9279","DOI":"10.1021\/acs.jmedchem.1c00532","article-title":"Systematic optimization of potent and orally bioavailable purine scaffold as a dual inhibitor of toll-like receptors 7 and 9","volume":"64","author":"Kundu","year":"2021","journal-title":"J. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425012279?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425012279?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T13:07:58Z","timestamp":1773925678000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425012279"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":59,"alternative-id":["S0223523425012279"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118462","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeted screening and rational optimization of bazedoxifene analogs as pan-variant SARS-CoV-2 entry inhibitors with improved pharmacokinetics","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118462","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118462"}}